(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
-2.67% $ 1.460
Live Chart Being Loaded With Signals
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 32 196.00 |
Średni wolumen | 73 856.00 |
Kapitalizacja rynkowa | 7.99M |
EPS | $0 ( 2024-04-01 ) |
Następna data zysków | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.0250 (1.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Purcell Michael J. | Buy | 50 000 | Restricted Stock Units |
2024-03-05 | Purcell Michael J. | Buy | 0 | |
2024-02-19 | Block Timothy M. | Buy | 85 000 | Stock Options |
2024-02-19 | Jacob Gary S | Buy | 85 000 | Stock Options |
2024-02-19 | Lbiati Kaouthar | Buy | 85 000 | Stock Options |
INSIDER POWER |
---|
93.72 |
Last 96 transactions |
Buy: 8 825 675 | Sell: 984 166 |
Hepion Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
ATCX | 0.925 |
SYKE | 0.923 |
RDUS | 0.907 |
BRACU | 0.898 |
ICON | 0.898 |
JFIN | 0.89 |
SPRB | 0.89 |
BGXX | 0.885 |
MESA | 0.88 |
UCL | 0.879 |
10 Najbardziej negatywne korelacje | |
---|---|
VERA | -0.896 |
ARDS | -0.879 |
LGHL | -0.848 |
IMRA | -0.848 |
AHPI | -0.843 |
TUEM | -0.838 |
HRMY | -0.835 |
SBBP | -0.834 |
VIEW | -0.833 |
IMPP | -0.825 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Hepion Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-67 131.00 (0.00 %) |
EPS: | $-12.32 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-67 131.00 (0.00 %) |
EPS: | $-12.32 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-77 461.00 (0.00 %) |
EPS: | $-11.07 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.38 |
Financial Reports:
No articles found.
Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej